SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Palvella Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 5:31 pm Purchase | 2025-09-30 | 13G | Palvella Therapeutics, Inc. PVLA | SUVRETTA CAPITAL MANAGEMENT, LLC | 822,400 7.400% | 107,937 (+15.11%) | Filing |
| 2024-12-20 4:56 pm Purchase | 2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA | SUVRETTA CAPITAL MANAGEMENT, LLC | 714,463 8.600% | 714,463 (New Position) | Filing |